Aclarion awards 100,000 RSUs to executive chair

Thramann Jeffrey John reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Thramann Jeffrey John reported acquisition or exercise transactions in this Form 4 filing.

Aclarion, Inc. reported that Executive Chairman Jeffrey John Thramann received a grant of 100,000 restricted stock units (RSUs) of common stock. Each RSU represents a contingent right to receive one share of Aclarion common stock.

All of the RSUs are scheduled to vest on June 1, 2027, and any outstanding unvested RSUs will fully vest if a change of control occurs as defined under the company’s equity incentive plan. Following this grant, Thramann holds 100,000 shares/RSUs directly.

Insider Trade Summary

Net Buyer: 100,000 shares

Net Buy 1 txn

Insider Thramann Jeffrey John

Role Executive Chairman

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	100,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 100,000 shares (Direct)

Footnotes (2)

1. F1. The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan. Each RSU represents a contingent right to receive one share of ACON common stock.
2. F2. 100% of the RSUs shall vest on 6/1/2027. Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control (as defined in the Company's equity incentive plan).

Key Figures

RSUs granted: 100,000 units Grant price: $0.00 per share Vesting date: June 1, 2027 +1 more

4 metrics

RSUs granted 100,000 units Restricted stock units granted on June 11, 2026

Grant price $0.00 per share Stated price for RSU acquisition

Vesting date June 1, 2027 100% of RSUs vest on this date

Post-transaction holdings 100,000 shares/RSUs Total direct holdings after the grant

Key Terms

restricted stock units ("RSUs"), equity incentive plan, change of control

3 terms

restricted stock units ("RSUs") financial

"The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

equity incentive plan financial

"The shares reported are RSUs granted under the Company's equity incentive plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

change of control financial

"Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control."

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

FAQ

What insider transaction did Aclarion (ACON) report for Jeffrey Thramann?

Aclarion reported that Executive Chairman Jeffrey John Thramann received a grant of 100,000 restricted stock units. These RSUs are a form of equity compensation and each unit represents a contingent right to receive one share of Aclarion common stock if and when they vest.

How many Aclarion (ACON) RSUs were granted to Jeffrey Thramann and at what price?

Jeffrey Thramann was granted 100,000 restricted stock units of Aclarion common stock at a stated grant price of $0.00 per share. This indicates the units were awarded as compensation rather than purchased in the open market or through a standard share acquisition transaction.

When do Jeffrey Thramann’s Aclarion (ACON) RSUs vest?

All of Jeffrey Thramann’s 100,000 Aclarion RSUs are scheduled to vest on June 1, 2027. Vesting means the units convert into shares deliverable to him, subject to the terms and conditions of Aclarion’s equity incentive plan governing the restricted stock units.

What happens to Aclarion (ACON) RSUs if there is a change of control?

Any of Jeffrey Thramann’s Aclarion RSUs that are still unvested will fully vest if a change of control occurs. The term change of control is defined in Aclarion’s equity incentive plan, and this provision accelerates vesting upon such a qualifying corporate transaction.

How many Aclarion (ACON) shares does Jeffrey Thramann hold after this RSU grant?

After the RSU grant, Jeffrey Thramann’s direct holdings reported in the filing total 100,000 shares or RSUs. This post-transaction figure reflects the equity reported as beneficially owned following the grant under the non-derivative securities section of the insider filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thramann Jeffrey John

(Last) (First) (Middle)

C/O ACLARION, INC.

8181 ARISTA PLACE, SUITE 100

(Street)

BROOMFIELD COLORADO 80021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aclarion, Inc. [ ACON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		100,000(1)(2)	A	$0.00	100,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan. Each RSU represents a contingent right to receive one share of ACON common stock.

2. 100% of the RSUs shall vest on 6/1/2027. Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control (as defined in the Company's equity incentive plan).

	/s/ Jeff Thramann	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)